Home > PE Ratio > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of SOLARA ACTIVE PHARMA SCIENCES is 418.12.

Share Price ₹556.1Dec 29,2025
Market Cap ₹2,680.2 Cr
Earnings-TTM₹6.4 CrTTM-Consolidated Results
Price/Earnings418.12xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of SOLARA ACTIVE PHARMA SCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SOLARA ACTIVE PHARMA SCIENCES is calculated as :

Current Market Cap [ ₹2,680.2 Cr] as on Dec 29,2025

(/) Earnings [ ₹6.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 418.12x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SOLARA ACTIVE PHARMA SCIENCES , the investors are currently willing to pay 418.12 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SOLARA ACTIVE PHARMA SCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SOLARA ACTIVE PHARMA SCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of SOLARA ACTIVE PHARMA SCIENCES


PE Ratio Performance Analysis for SOLARA ACTIVE PHARMA SCIENCES

- SOLARA ACTIVE PHARMA SCIENCES 's latest p/e ratio is 418.12x.

- SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 768.61x.

- SOLARA ACTIVE PHARMA SCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio peaked in Mar2025 at 3820.42x.

- SOLARA ACTIVE PHARMA SCIENCES 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does SOLARA ACTIVE PHARMA SCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SOLARA ACTIVE PHARMA SCIENCES 6.41418.122,680.2
SUN PHARMACEUTICAL INDUSTRIES LTD10,517.9039.18412,086.0
DIVIS LABORATORIES LTD2,485.0068.26169,616.0
CIPLA LTD5,453.8622.13120,713.0
TORRENT PHARMACEUTICALS LTD2,140.0059.98128,361.0
DR REDDYS LABORATORIES LTD5,721.4018.51105,881.0
MANKIND PHARMA LTD1,767.0650.9790,069.9
ZYDUS LIFESCIENCES LTD4,973.4018.2990,963.5
LUPIN LTD4,347.5321.8594,991.3
AUROBINDO PHARMA LTD3,447.7520.2069,638.1
ABBOTT INDIA LTD1,508.9540.7261,440.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SOLARA ACTIVE PHARMA SCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.29x
Max industry PE 418.12x
Median industry PE 39.18x
Average industry PE 70.75x



You may also like the below Video Courses